Cargando…
Maternal total cell-free DNA in preeclampsia with and without intrauterine growth restriction
Elevation of total cell-free DNA (cfDNA) in patients with preeclampsia is well-known; however, whether this change precedes the onset of symptoms remains inconclusive. Here, we conducted a nested case–control study to determine the elevation of cfDNA levels in women who subsequently developed preecl...
Autores principales: | Kwak, Dong Wook, Kim, Shin Young, Kim, Hyun Jin, Lim, Ji Hyae, Kim, Young-Han, Ryu, Hyun Mee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367308/ https://www.ncbi.nlm.nih.gov/pubmed/32678284 http://dx.doi.org/10.1038/s41598-020-68842-1 |
Ejemplares similares
-
Quantification and Application of Potential Epigenetic Markers in Maternal Plasma of Pregnancies with Hypertensive Disorders
por: Kim, Hyun Jin, et al.
Publicado: (2015) -
Cell-Free Fetal DNA and Cell-Free Total DNA Levels in Spontaneous Abortion with Fetal Chromosomal Aneuploidy
por: Lim, Ji Hyae, et al.
Publicado: (2013) -
Non-invasive prenatal diagnosis of fetal trisomy 21 using cell-free fetal DNA in maternal blood
por: Lim, Ji Hyae, et al.
Publicado: (2013) -
Maternal Serum Levels of VCAM-1, ICAM-1 and E-selectin in Preeclampsia
por: Kim, Shin-Young, et al.
Publicado: (2004) -
Non-Invasive Prenatal Testing of Trisomy 18 by an Epigenetic Marker in First Trimester Maternal Plasma
por: Lee, Da Eun, et al.
Publicado: (2013)